Save your place

Sign in to WhoBought

Please try again later.

Travere Therapeutics, Inc. (TVTX) institutional ownership

Latest close $57.85 Jul 7, 2026
Market cap$2.0B 52-week range SectorHealthcare
Funds holding · Q1 2026
280
reported TVTX position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Net sold $26M
131 buyers · 149 sellers

Travere Therapeutics, Inc. (TVTX) price and institutional activity

Dates

Q1 2026

$394M bought by 131 investors
FMR LLC$40MArmistice Capital, LLC$34M +129 more
$420M sold by 149 investors
Adage Capital Partners Gp, L.L.C.-$58MMorgan Stanley-$33M +147 more
Sign in to see who bought
Bought Sold Totals per quarter; hover a bar for the names.

Travere Therapeutics, Inc. (TVTX) institutional activity · 280

Investor Type Est. change Change Δ Own Date
Adage Capital Partners Gp, L.L.C. · Reduced −$58M
Change −1.9M Date Q1 2026
Adage Capital Partners Gp, L.L.C. Reduced· Q1 2026 −$58M −1.9M Q1 2026
FMR LLC · Added +$40M
Change +1.4M Δ Own +14.0% Date Q1 2026
FMR LLC Added· Q1 2026 +$40M +1.4M +14.0% Q1 2026
Armistice Capital, LLC · Added +$34M
Change +1.1M Date Q1 2026
Armistice Capital, LLC Added· Q1 2026 +$34M +1.1M Q1 2026
Mpm Bioimpact LLC · New +$34M
Change +1.1M Date Q1 2026
Mpm Bioimpact LLC New· Q1 2026 +$34M +1.1M Q1 2026
Morgan Stanley · Reduced −$33M
Change −1.1M Date Q1 2026
Morgan Stanley Reduced· Q1 2026 −$33M −1.1M Q1 2026
Kynam Capital Management, LP · Added +$31M
Change +1.1M Date Q1 2026
Kynam Capital Management, LP Added· Q1 2026 +$31M +1.1M Q1 2026
Janus Henderson Group PLC · Added +$27M
Change +908K Date Q1 2026
Janus Henderson Group PLC Added· Q1 2026 +$27M +908K Q1 2026
Voloridge Investment Management, LLC · Reduced −$23M
Change −753K Date Q1 2026
Voloridge Investment Management, LLC Reduced· Q1 2026 −$23M −753K Q1 2026
Ra Capital Management, L.P. · New +$22M
Change +747K Date Q1 2026
Ra Capital Management, L.P. New· Q1 2026 +$22M +747K Q1 2026
Rock Springs Capital Management LP · Reduced −$22M
Change −732K Date Q1 2026
Rock Springs Capital Management LP Reduced· Q1 2026 −$22M −732K Q1 2026
Two Sigma Advisers, LP · Exited −$22M
Change −726K Δ Own −100.0% Date Q1 2026
Two Sigma Advisers, LP Exited· Q1 2026 −$22M −726K −100.0% Q1 2026
Tang Capital Management LLC · Exited −$21M
Change −700K Δ Own −100.0% Date Q1 2026
Tang Capital Management LLC Exited· Q1 2026 −$21M −700K −100.0% Q1 2026
Eversept Partners, LP · Reduced −$19M
Change −632K Date Q1 2026
Eversept Partners, LP Reduced· Q1 2026 −$19M −632K Q1 2026
BNP Paribas Financial Markets · Reduced −$17M
Change −556K Date Q1 2026
BNP Paribas Financial Markets Reduced· Q1 2026 −$17M −556K Q1 2026
Soleus Capital Management, L.P. · New +$16M
Change +546K Date Q1 2026
Soleus Capital Management, L.P. New· Q1 2026 +$16M +546K Q1 2026
Data through Q1 2026 · filed Jun 2, 2026
15 of 280

Famous investor activity in Travere Therapeutics, Inc. (TVTX)

Travere Therapeutics, Inc. (TVTX) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Inrig Jula · Officer Gift (G) -468
Owned 113K ΔOwn −0.4% Trade date Jun 22, 2026 Filed date Jun 22, 2026
Inrig Jula Officer Gift (G) -468 113K −0.4% Jun 22, 2026 Jun 22, 2026
Coughlin Timothy · Director Sell −$501K
Price $50.07 Qty −10K Owned 56K Trade date Jun 12, 2026 Filed date Jun 16, 2026
Coughlin Timothy Director Sell $50.07 −10K −$501K 56K Jun 12, 2026 Jun 16, 2026
Coughlin Timothy · Director 2 operations 0
Price $26.52 Owned 0 Trade date Jun 12, 2026 Filed date Jun 16, 2026
Coughlin Timothy Director 2 operations $26.52 0 0 Jun 12, 2026 Jun 16, 2026
Baynes Roy D. · Director Sell −$225K
Price $50.00 Qty −4K Owned 42K Trade date Jun 12, 2026 Filed date Jun 16, 2026
Baynes Roy D. Director Sell $50.00 −4K −$225K 42K Jun 12, 2026 Jun 16, 2026
Baynes Roy D. · Director 2 operations 0
Price $21.38 Owned 0 Trade date Jun 12, 2026 Filed date Jun 16, 2026
Baynes Roy D. Director 2 operations $21.38 0 0 Jun 12, 2026 Jun 16, 2026
Williams Brinkley Ruth · Director 2 operations 16K
Owned 12K Trade date May 19, 2026 Filed date May 21, 2026
Williams Brinkley Ruth Director 2 operations 16K 12K May 19, 2026 May 21, 2026
Squarer Ron · Director 2 operations 16K
Owned 12K Trade date May 19, 2026 Filed date May 21, 2026
Squarer Ron Director 2 operations 16K 12K May 19, 2026 May 21, 2026
Poole Sandra · Director 2 operations 16K
Owned 12K Trade date May 19, 2026 Filed date May 21, 2026
Poole Sandra Director 2 operations 16K 12K May 19, 2026 May 21, 2026
Orwin John A. · Director 2 operations 16K
Owned 12K Trade date May 19, 2026 Filed date May 21, 2026
Orwin John A. Director 2 operations 16K 12K May 19, 2026 May 21, 2026
Meckler Jeffrey A. · Director 2 operations 16K
Owned 12K Trade date May 19, 2026 Filed date May 21, 2026
Meckler Jeffrey A. Director 2 operations 16K 12K May 19, 2026 May 21, 2026
Lyons Gary A. · Director 2 operations 16K
Owned 12K Trade date May 19, 2026 Filed date May 21, 2026
Lyons Gary A. Director 2 operations 16K 12K May 19, 2026 May 21, 2026
Coughlin Timothy · Director 2 operations 16K
Owned 12K Trade date May 19, 2026 Filed date May 21, 2026
Coughlin Timothy Director 2 operations 16K 12K May 19, 2026 May 21, 2026
Bruhn Suzanne Louise · Director 2 operations 16K
Owned 12K Trade date May 19, 2026 Filed date May 21, 2026
Bruhn Suzanne Louise Director 2 operations 16K 12K May 19, 2026 May 21, 2026
Baynes Roy D. · Director 2 operations 16K
Owned 12K Trade date May 19, 2026 Filed date May 21, 2026
Baynes Roy D. Director 2 operations 16K 12K May 19, 2026 May 21, 2026
Coughlin Timothy · Director Sell −$141K
Price $43.49 Qty −3K Owned 52K Trade date May 15, 2026 Filed date May 19, 2026
Coughlin Timothy Director Sell $43.49 −3K −$141K 52K May 15, 2026 May 19, 2026
15 of 116
15 of 116 Sign in to continue to older insider transactions.

Travere Therapeutics, Inc. (TVTX) activist and large shareholders

What are Schedules 13D and 13G?

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Vanguard Group Inc 6.9M
% of shares outstanding 9.0% Filing date Nov 12, 2024
Vanguard Group Inc 6.9M 9.0% Nov 12, 2024
Macquarie Group Ltd 4.7M
% of shares outstanding 6.3% Filing date Feb 14, 2024
Macquarie Group Ltd 4.7M 6.3% Feb 14, 2024
Rock Springs Capital Management LP
% of shares outstanding 5.8% Filing date May 1, 2024
Rock Springs Capital Management LP 5.8% May 1, 2024
Woodline Partners LP 4.3M
% of shares outstanding 5.7% Filing date Nov 14, 2024
Woodline Partners LP 4.3M 5.7% Nov 14, 2024
Armistice Capital, LLC 4.9M
% of shares outstanding 5.3% Filing date May 15, 2026
Armistice Capital, LLC 4.9M 5.3% May 15, 2026
Vanguard Capital Management 4.7M
% of shares outstanding 5.1% Filing date Apr 30, 2026
Vanguard Capital Management 4.7M 5.1% Apr 30, 2026
State Street Corp 2.7M
% of shares outstanding 3.6% Filing date Oct 18, 2024
State Street Corp 2.7M 3.6% Oct 18, 2024
Morgan Stanley 1.3M
% of shares outstanding 1.7% Filing date Nov 8, 2024
Morgan Stanley 1.3M 1.7% Nov 8, 2024
8 of 10

Travere Therapeutics, Inc. (TVTX) ownership FAQ

Who owns TVTX?

280 reporting institutions disclosed TVTX position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.